Pfizer Limited (PFIZER) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.156x

Based on the latest financial reports, Pfizer Limited (PFIZER) has a cash flow conversion efficiency ratio of 0.156x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs5.99 Billion ≈ $64.83 Million USD) by net assets (Rs38.48 Billion ≈ $416.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Pfizer Limited market capitalisation for the company's overall valuation and market capitalisation.

Pfizer Limited - Cash Flow Conversion Efficiency Trend (2005–2026)

This chart illustrates how Pfizer Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Pfizer Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pfizer Limited ranked by their cash flow conversion efficiency. Explore PFIZER operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
WK Kellogg Co
NYSE:KLG
0.072x
Dno ASA
OL:DNO
0.225x
Resolute Mining Ltd
AU:RSG
0.174x
RLX TECH. SP.ADR/1 CL.A
F:3CM
0.020x
Kangwon Land
KO:035250
0.030x
Cimpress NV
NASDAQ:CMPR
-0.277x
Jiangsu Leili Motor Corp Ltd
SHE:300660
0.022x
Zenas BioPharma, Inc. Common Stock
NASDAQ:ZBIO
-0.224x

Annual Cash Flow Conversion Efficiency for Pfizer Limited (2005–2026)

The table below shows the annual cash flow conversion efficiency of Pfizer Limited from 2005 to 2026. View PFIZER stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs42.03 Billion
≈ $454.53 Million
Rs11.44 Billion
≈ $123.67 Million
0.272x +73.94%
2025-03-31 Rs42.17 Billion
≈ $456.10 Million
Rs6.60 Billion
≈ $71.35 Million
0.156x +119.00%
2024-03-31 Rs35.96 Billion
≈ $388.84 Million
Rs2.57 Billion
≈ $27.78 Million
0.071x -35.59%
2023-03-31 Rs32.07 Billion
≈ $346.86 Million
Rs3.56 Billion
≈ $38.47 Million
0.111x -52.38%
2022-03-31 Rs28.64 Billion
≈ $309.78 Million
Rs6.67 Billion
≈ $72.14 Million
0.233x +30.42%
2021-03-31 Rs23.93 Billion
≈ $258.80 Million
Rs4.27 Billion
≈ $46.21 Million
0.179x +87.62%
2020-03-31 Rs33.95 Billion
≈ $367.21 Million
Rs3.23 Billion
≈ $34.95 Million
0.095x +193.03%
2019-03-31 Rs30.11 Billion
≈ $325.66 Million
Rs978.10 Million
≈ $10.58 Million
0.032x -73.73%
2018-03-31 Rs26.83 Billion
≈ $290.18 Million
Rs3.32 Billion
≈ $35.88 Million
0.124x -9.03%
2017-03-31 Rs24.19 Billion
≈ $261.59 Million
Rs3.29 Billion
≈ $35.56 Million
0.136x -16.22%
2016-03-31 Rs21.18 Billion
≈ $229.05 Million
Rs3.44 Billion
≈ $37.16 Million
0.162x +182.10%
2015-03-31 Rs19.73 Billion
≈ $213.37 Million
Rs1.13 Billion
≈ $12.27 Million
0.058x -71.41%
2014-03-31 Rs6.58 Billion
≈ $71.20 Million
Rs1.32 Billion
≈ $14.32 Million
0.201x +4060.27%
2013-03-31 Rs16.94 Billion
≈ $183.25 Million
Rs-86.07 Million
≈ $-930.79K
-0.005x -127.10%
2012-03-31 Rs13.05 Billion
≈ $141.10 Million
Rs244.59 Million
≈ $2.65 Million
0.019x -86.64%
2011-03-31 Rs11.63 Billion
≈ $125.82 Million
Rs1.63 Billion
≈ $17.66 Million
0.140x +86.88%
2010-03-31 Rs9.94 Billion
≈ $107.53 Million
Rs746.73 Million
≈ $8.08 Million
0.075x -71.54%
2009-03-31 Rs9.01 Billion
≈ $97.45 Million
Rs2.38 Billion
≈ $25.71 Million
0.264x +941.98%
2008-03-31 Rs6.50 Billion
≈ $70.26 Million
Rs164.53 Million
≈ $1.78 Million
0.025x -90.96%
2007-03-31 Rs4.40 Billion
≈ $47.56 Million
Rs1.23 Billion
≈ $13.32 Million
0.280x +2.51%
2006-03-31 Rs3.76 Billion
≈ $40.66 Million
Rs1.03 Billion
≈ $11.11 Million
0.273x +6.40%
2005-03-31 Rs3.40 Billion
≈ $36.72 Million
Rs872.08 Million
≈ $9.43 Million
0.257x --

About Pfizer Limited

NSE:PFIZER India Drug Manufacturers - General
Market Cap
$1.99 Billion
Rs183.67 Billion INR
Market Cap Rank
#6215 Global
#280 in India
Share Price
Rs4014.80
Change (1 day)
+0.01%
52-Week Range
Rs4014.40 - Rs5529.50
All Time High
Rs6318.30
About

Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers therapy area and products, such as vaccines, injectables and anti-infectives, inflammation and immunology, and internal medicine for cardiovascular care, oncology, respiratory, multivitamins and multimineral, neuroscience, women's health, gastroenterolog… Read more